| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA629257 | A | Thermal denaturation of calf thymus DNA measured as Tm | Bos taurus | 3 | organism-based format | Scientific Literature | ||
| 2. | ALA651518 | F | In vitro 50% Growth inhibition of sensitive B16 cells. | Mus musculus | 3 | cell-based format | Scientific Literature | ||
| 3. | ALA708181 | F | Optimal dose per injection, administered ip on days 1, 5, and 9, ip inoculation with 10E5 L1210 cells per CDF1 mouse on day 0. | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 4. | ALA702136 | F | Inhibition of synthesis of [5-3H]-uridine into RNA in L1210 cells. | Mus musculus | 3 | cell-based format | Scientific Literature | ||
| 5. | ALA702137 | F | Inhibition of synthesis of [methyl-14C] thymidine into DNA, in L1210 cells. | Mus musculus | 3 | cell-based format | Scientific Literature | ||
| 6. | ALA704723 | F | 50% Inhibition of growth of L1210 cells in culture. | Mus musculus | 3 | cell-based format | Scientific Literature | ||
| 7. | ALA740519 | F | Antitumor activity measured as optimal dose, for ip administration of compound and ip inoculation of B16 melanoma. | Mus musculus | 4 | organism-based format | Scientific Literature | ||
| 8. | ALA740520 | F | Antitumor activity measured as optimal dose, for sc administration of compound and iv inoculation of B16 melanoma. | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 9. | ALA740521 | F | Antitumor activity measured as optimal dose, against C26 colon carcinoma. | Mus musculus | 4 | organism-based format | Scientific Literature | ||
| 10. | ALA735957 | F | percent increase in median life time (%ILS) measured in mice bearing leukemia L!210 | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 11. | ALA736627 | F | Antitumor activity measured as % increase in life span, for ip administration of compound and ip inoculation of B16 melanoma. | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 12. | ALA736628 | F | Antitumor activity measured as % increase in life span, for sc administration of compound and iv inoculation of B16 melanoma. | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 13. | ALA743511 | F | Antitumor activity measured as % increase in life span, against C26 colon carcinoma. | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA743513 | F | Antitumor activity measured as median survival time, for ip administration and ip inoculation of B16 melanoma. | Mus musculus | 4 | organism-based format | Scientific Literature | ||
| 15. | ALA743514 | F | Antitumor activity measured as median survival time, for sc administration and iv inoculation of B16 melanoma. | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 16. | ALA743516 | F | Antitumor activity measured as median survival time, against C26 colon carcinoma. | Mus musculus | 4 | organism-based format | Scientific Literature | ||
| 17. | ALA757434 | F | Antitumor activity against P388/ADR, in ip implanted CDF1 mice, treated ip, qd 1-9 measured as optimal dose | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 18. | ALA757438 | F | In vitro 50% Growth inhibition of actinomycin resistant P388/ADR cells | Mus musculus | 3 | cell-based format | Scientific Literature | ||
| 19. | ALA757440 | F | Antitumor activity measured as %ILS against P388/ADR, in ip implanted CDF1 mice, treated ip, qd 1-9 | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 20. | ALA755226 | F | Antitumor activity measured as Median survival time in days against P388/ADR, in ip implanted CDF1 mice, treated ip, qd 1-9 | Mus musculus | 3 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!